UroGen Pharma to Participate in the B. Riley Healthcare Conference

Rhea-AI Summary

UroGen Pharma Ltd. (Nasdaq: URGN) announced that Liz Barrett, President and CEO, will participate in a fireside chat at the upcoming B. Riley Virtual Healthcare Conference on January 18th at 12:00 p.m. ET. The event will be available for replay on UroGen's investor website for approximately 30 days.

- Fireside Chat January 18, 2024, at 12:00 pm ET -

PRINCETON, N.J.--(BUSINESS WIRE)-- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that Liz Barrett, President and CEO, will participate in a fireside chat at the upcoming B. Riley Virtual Healthcare Conference on January 18^th beginning at 12:00 p.m. ET.

To access the event, please RSVP to your B. Riley Securities sales representative. Following the event, a replay of the fireside chat will be available at the "Events and Presentations" section of UroGen’s investor website for approximately 30 days.

About UroGen Pharma Ltd.

UroGen is a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options. UroGen has developed RTGel® reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen’s sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. Jelmyto® (mitomycin) for pyelocaliceal solution and investigational treatment UGN-102 (mitomycin) for intravesical solution are designed to ablate tumors by non-surgical means. UroGen is headquartered in Princeton, NJ with operations in Israel. Visit www.urogen.com to learn more or follow us on Twitter, @UroGenPharma.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240111451437/en/

INVESTOR CONTACT:

Vincent Perrone

Senior Director, Investor Relations

vincent.perrone@urogen.com

609-460-3588

MEDIA CONTACT:

Cindy Romano

Director, Communications

cindy.romano@urogen.com

908-963-7827

Source: UroGen Pharma Ltd.

FAQ

What is the upcoming event that UroGen Pharma Ltd. (Nasdaq: URGN) announced?

UroGen Pharma Ltd. (Nasdaq: URGN) announced that Liz Barrett, President and CEO, will participate in a fireside chat at the upcoming B. Riley Virtual Healthcare Conference.

When will the fireside chat take place?

The fireside chat will take place on January 18th at 12:00 p.m. ET.

Where can the event be accessed?

To access the event, please RSVP to your B. Riley Securities sales representative.

Where can the replay of the fireside chat be found?

A replay of the fireside chat will be available at the 'Events and Presentations' section of UroGen’s investor website for approximately 30 days.